Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
The UK's psychedelic drugs market is growing rapidly due to the increasing prevalence of depression and other mental illnesses worldwide, according to a report from Data Bridge. The growth is likely to attract major investments in the near future.
Source: prnewswire.comPublished on 2021-10-05
Related news
- The New Humanitarian | Is it possible to predict future forced displacement ?
- Greece Signs Agreement With Amazon For Innovation Space Hub
- Origin Launches Airbrush , A Universal Data Standard Aiming To Optimise Bond Issuance
- Diameter Health and Smile CDR Announce Partnership to Provide Best - of - Breed FHIR Solutions
- Food Safety : CMX and FDA - Challenge Winner Mojix Partner to Launch First Open Access Food Traceability Platform
- Trace Labs , the OriginTrail core team , receives support from the World Economic Forum to ensure safer buying of COVID - 19 protective equipment using blockchain
- Codat Announces Partnership with Intuit to Speed QuickBooks App Development And Catalyze New Wave of Open Finance
- The progress of Open Banking and road ahead
- RMS Launches New Climate Change Models
- Taking Ocean Vital Signs
- Why demand is strong for Canada 6 new immigration programs
- Corelight Secures $75 Million in Series D Funding Led by Energy Impact Partners
- Biotech Companies Driving Psychedelics Industry Forward with Key Research
- Book Review | The City is Not A Computer - Spacing National